Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shekhar Ghamande

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
The Journal of Infectious Diseases|March 8, 2023
Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron VariantsDerek E Dimcheff, Christopher N Blair, Yuwei Zhu, et al.
JAMA Network Open|April 1, 2025
Patient- and Community-Level Characteristics Associated With Respiratory Syncytial Virus VaccinationDiya Surie, Katharine A Yuengling, Basmah Safdar, et al.
Vaccine|June 10, 2023
Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report-IVY Network, February 1-August 31, 2022Diya Surie, Levi N Bonnell, Jennifer DeCuir, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 31, 2023
Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022Noah Kojima, Katherine Adams, Wesley H Self, et al.
The Journal of Infectious Diseases|April 8, 2025
Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations-United States, September 1, 2023-May 31, 2024Nathaniel M Lewis, Elizabeth J Harker, Seana Cleary, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2023
Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023Nathaniel M Lewis, Yuwei Zhu, Ithan D Peltan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 25, 2025
Multimorbidity Profiles and Severe In-Hospital Outcomes in Adults with Respiratory Syncytial VirusKevin C Ma, Diya Surie, Yuwei Zhu, et al.
Vaccine|November 8, 2024
Assessment and mitigation of bias in influenza and COVID-19 vaccine effectiveness analyses - IVY Network, September 1, 2022-March 30, 2023Nathaniel M Lewis, Elizabeth J Harker, Aleda Leis, et al.
JAMA|August 30, 2025
RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 SeasonsDiya Surie, Wesley H Self, Katharine A Yuengling, et al.
JAMA Network Open|February 3, 2026
Estimated Effectiveness of 2024-2025 COVID-19 Vaccination Against Severe COVID-19Kevin C Ma, Alexander Webber, Adam S Lauring, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
The Journal of Infectious Diseases|March 8, 2023
Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron VariantsDerek E Dimcheff, Christopher N Blair, Yuwei Zhu, et al.
JAMA Network Open|April 1, 2025
Patient- and Community-Level Characteristics Associated With Respiratory Syncytial Virus VaccinationDiya Surie, Katharine A Yuengling, Basmah Safdar, et al.
Vaccine|June 10, 2023
Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report-IVY Network, February 1-August 31, 2022Diya Surie, Levi N Bonnell, Jennifer DeCuir, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 31, 2023
Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022Noah Kojima, Katherine Adams, Wesley H Self, et al.
The Journal of Infectious Diseases|April 8, 2025
Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations-United States, September 1, 2023-May 31, 2024Nathaniel M Lewis, Elizabeth J Harker, Seana Cleary, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2023
Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023Nathaniel M Lewis, Yuwei Zhu, Ithan D Peltan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 25, 2025
Multimorbidity Profiles and Severe In-Hospital Outcomes in Adults with Respiratory Syncytial VirusKevin C Ma, Diya Surie, Yuwei Zhu, et al.
Vaccine|November 8, 2024
Assessment and mitigation of bias in influenza and COVID-19 vaccine effectiveness analyses - IVY Network, September 1, 2022-March 30, 2023Nathaniel M Lewis, Elizabeth J Harker, Aleda Leis, et al.
JAMA|August 30, 2025
RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 SeasonsDiya Surie, Wesley H Self, Katharine A Yuengling, et al.
JAMA Network Open|February 3, 2026
Estimated Effectiveness of 2024-2025 COVID-19 Vaccination Against Severe COVID-19Kevin C Ma, Alexander Webber, Adam S Lauring, et al.
Pageof 9